{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:03:31Z","timestamp":1761901411509,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.msard.2018.07.016","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T22:44:30Z","timestamp":1531262670000},"page":"26-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Myocardial infarction in a patient with multiple sclerosis after receiving natalizumab"],"prefix":"10.1016","volume":"25","author":[{"given":"Aala","family":"Darki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiman","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbas","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdorreza","family":"Naser Moghadasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2018.07.016_bib0001","first-page":"675","article-title":"An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations","volume":"9","author":"Barbara","year":"2015","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"10.1016\/j.msard.2018.07.016_bib0002","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/ene.12598","article-title":"Increased risk of ischaemic stroke among patients with multiple sclerosis","volume":"22","author":"Tseng","year":"2015","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2018.07.016_bib0003","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1515\/cclm-2016-0010","article-title":"Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management","volume":"54","author":"Kounis","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.msard.2018.07.016_bib0004","doi-asserted-by":"crossref","DOI":"10.4161\/onci.27987","article-title":"Adverse cardiac events to monoclonal antibodies used for cancer therapy: the risk of Kounis syndrome","volume":"3","author":"Kounis","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.msard.2018.07.016_bib0005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1352458510385508","article-title":"Kinetics and incidence of anti-natalizumab antibodies in multiple sclerosis patients on treatment for 18 months","volume":"17","author":"Oliver","year":"2011","journal-title":"Mult. Scler."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818302232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034818302232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:44:41Z","timestamp":1761900281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034818302232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":5,"alternative-id":["S2211034818302232"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2018.07.016","relation":{},"ISSN":["2211-0348"],"issn-type":[{"type":"print","value":"2211-0348"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial infarction in a patient with multiple sclerosis after receiving natalizumab","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2018.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}